SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Park Ha Biological Technology Co., Ltd. (PHH) 当前追踪市盈率 (P/E) 为 21.0. 追踪盈利收益率为 4.75%.
本页证实的标准:
- VALUE (75/100, 通过) — 市盈率低于市场平均水平 (21.0); 盈利收益率超过债券收益率 (4.75%).
- 追踪盈利收益率 4.75% — 与债券收益率（约4.3%）大致持平，风险回报适中。
SharesGrow 综合评分： 79/100 其中 4/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
75/100
Price-to-Earnings & upside
Proven by this page
✓
健康
100/100
Debt-to-Equity & liquidity
→ Health
估值概览 — PHH
估值倍数
P/E (TTM)21.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率4.23
EV/EBITDA0.0
每股数据
EPS (TTM)$0.02
每股账面价值$0.00
每股营收$0.09
每股自由现金流$0.00
收益率与内在价值
盈利收益率4.75%
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2012 |
$0.56 |
$2.74B |
$34M |
1.2% |
| 2013 |
$2.06 |
$2.84B |
$135M |
4.8% |
| 2014 |
$-3.36 |
$639M |
$-185M |
-29% |
| 2015 |
$-2.37 |
$790M |
$-131M |
-16.6% |
| 2016 |
$-3.60 |
$622M |
$-193M |
-31% |
| 2017 |
$-4.14 |
$456M |
$-194M |
-42.5% |
| 2021 |
$-0.02 |
$931.04K |
$-485K |
-52.1% |
| 2022 |
$0.01 |
$1.92M |
$191.3K |
10% |
| 2023 |
$0.03 |
$2.46M |
$852.04K |
34.6% |
| 2024 |
$0.02 |
$2.38M |
$478.56K |
20.1% |
